Fetal death

被引:118
作者
Silver, Robert M. [1 ]
机构
[1] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA
关键词
D O I
10.1097/01.AOG.0000248537.89739.96
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The death of a formed fetus is one of the most emotionally devastating events for parents and clinicians. With improved care for conditions such as RhD alloimmunization, diabetes, and preeclampsia, the rate of fetal death in the United States decreased substantially in the mid twentieth century. However, the past several decades have seen much greater reductions in neonatal death rates than in fetal death rates. As such, fetal death remains a significant and understudied problem that now accounts for almost 50% of all perinatal deaths. The availability of prostaglandins has greatly facilitated delivery options for patients with fetal death. Risk factors for fetal death include African American race, advanced maternal age, obesity, smoking, prior fetal death, maternal diseases, and fetal growth impairment. There are numerous causes of fetal death, including genetic conditions, infections, placental abnormalities, and fetal-maternal hemorrhage. Many cases of fetal death do not undergo adequate evaluation for possible causes. Perinatal autopsy and placental examination are perhaps the most valuable tests for the evaluation of fetal death. Antenatal surveillance and emotional support are the mainstays of subsequent pregnancy management. Outcomes may be improved in women with diabetes, hypertension, red cell alloimmunization, and anti phospholipid syndrome. However, there is considerable room for further reduction in the fetal death rate.
引用
收藏
页码:153 / 167
页数:15
相关论文
共 40 条
[1]  
[Anonymous], 1993, Int J Gynaecol Obstet, V42, P291
[2]  
BAIRD D, 1954, J OBSTET GYN BRIT EM, V61, P433
[3]   Higher rate of stillbirth at the extremes of reproductive age: A large nationwide sample of deliveries in the United States [J].
Bateman, BT ;
Simpson, LL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 194 (03) :840-845
[4]   Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates [J].
Beischer, NA ;
Wein, P ;
Sheedy, MT ;
Steffen, B .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1996, 36 (03) :239-247
[5]   EFFECT OF CHANGING THE STILLBIRTH DEFINITION ON EVALUATION OF PERINATAL-MORTALITY RATES [J].
CARTLIDGE, PHT ;
STEWART, JH .
LANCET, 1995, 346 (8973) :486-488
[6]   Comparative genomic hybridization for cytogenetic evaluation of stillbirth [J].
Christiaens, GCML ;
Vissers, J ;
Poddighe, PJ ;
De Pater, JM .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (02) :281-286
[7]   Perinatal outcome in SGA births defined by customised versus population-based birthweight standards [J].
Clausson, B ;
Gardosi, J ;
Francis, A ;
Cnattingius, S .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (08) :830-834
[8]   Perinatal mortality in Type 2 diabetes mellitus [J].
Cundy, T ;
Gamble, G ;
Townend, K ;
Henley, PG ;
MacPherson, P ;
Roberts, AB .
DIABETIC MEDICINE, 2000, 17 (01) :33-39
[9]   Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery [J].
Dickinson, JE .
OBSTETRICS AND GYNECOLOGY, 2005, 105 (02) :352-356
[10]   The relationship of the factor v Leiden mutation and pregnancy outcomes for mother and fetus [J].
Dizon-Townson, D ;
Miller, C ;
Sibai, B ;
Spong, CY ;
Thom, E ;
Wendel, G ;
Wenstrom, K ;
Samuels, P ;
Cotroneo, MA ;
Moawad, A ;
Sorokin, Y ;
Meis, P ;
Miodovnik, M ;
O'Sullivan, M ;
Conway, D ;
Wapner, RJ ;
Gabbe, SG .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (03) :517-524